Ontuxizumab (MORAb-004) is a potent IgG1/kappa monoclonal antibody targeting endomelanic acid with anti-tumor effects. It specifically targets endothelin (TEM-1 or CD248) and is used for the treatment of metastatic melanoma.
Purity:
>95%
CAS Number:
[946415-62-9]
Target:
Others|||EGFR
* VAT and and shipping costs not included. Errors and price changes excepted